On October 25-26, 2016, the U
When incidents occur during critical phases of flight such as takeoffs, landings, low altitude maneuvers and emergencies, there is potential for an aircraft accident.
Even if a pilot can safely handle the aircraft, there may be disruption of a task such as a police helicopter going after the laser perpetrator instead of completing its original mission. 9 (The Coast Guard has strict rules about returning to base after laser exposures, which have interrupted rescue missions. 10 )
Pilot eye effects and injuries
Understandably, pilots are also concerned over the possibility of high-powered laser light causing temporary eye effects such as pain and watering eyes, or worse, temporary 11 or even permanent eye injuries.
An April 2016 overview of consumer laser hazards by laser safety experts John Marshall, John O'Hagan, and John Tyrer concluded that permanent eye injuries to pilots are highly unlikely: "Fortunately, these exposures are at irradiances that are incapable of producing irreversible retinal damage even at distances of 100 m." 12 They stated there had been only one case of alleged retinal damage; that this case was suspect for a number of reasons; and that they do not believe ground-to-air laser targeting caused the injury.
A call for restrictions on laser pointers
As of January 2017, there have been over 54,000 laser illuminations reported in five countries including the U.S., 13 fortunately with no accidents and (apparently) no permanent eye injuries thus far.
14 But pilot groups in the U.K., Canada and New Zealand have called for restrictions on laser pointer sale, possession and/or use. Some examples:
• In January 2017, the head of the New Zealand Air Line Pilots' Association wanted a total ban on lasers over 1 milliwatt: "There is a current law that prevents the importation and sale of these high-powered lasers unless there is a specific reason for their use. But we see that the danger outweighs the utility of them and we would like to see a complete ban."
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• In September 2016, the British Airline Pilots' Association called for high-powered lasers to be treated as offensive weapons.
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• In August 2016, the head of the U.K. Civil Aviation Authority said that persons carrying high-powered laser pointers in public should be arrested even if they are not using them.
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• • Medical laser products • Demonstration laser products 23 • Surveying, leveling, and alignment ("SLA") laser products 24 The word "pointer" or the concept of a handheld laser device does not appear in 21 CFR 1040.10 and 1040.11, which were issued in 1976 before consumer handheld laser devices were developed. Around 1989-1990 FDA began to take notice of these devices and to control them as SLA products "because they described a straight line from the lecturer to the point on the screen to which attention was being directed."
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Other "products that FDA has considered to be SLA products ... include products described as target pointer illuminator aiming, tactical laser illuminator, infrared zoom illuminator, and laser illuminator. Illuminator, alignment, target designation, pointing, or any similar description of a laser product for use in alignment or positioning provides a basis for classification of a laser product as a surveying, leveling, or alignment laser product."
26
In addition, hand-held lasers promoted for entertainment purposes or amusement also meet the demonstration laser product definition.
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Both SLA and demonstration products are limited by 21 CFR 1040.11(b) and (c) to 5 milliwatts output power in the visible wavelength range from 400 to 710 nanometers.
Labeling
FDA requires caution labels on Class II laser pointers (IEC Class 2, up to 1 mW) and warning labels on Class IIIa (IEC Class 3R, 1-5mW) laser pointer products. These labels warn "Do not stare into beam" and "Avoid direct eye exposure."
FDA does not currently have regulations that require labels that warn of indirect (non-health) hazards such as visual interference with operators of aircraft, vehicles and watercraft. FDA does ask manufacturers to voluntarily add a visual effect caution statement when labeling SLA products. 28 The suggestion is automatically added to acknowledgment letters that FDA sends in response to an SLA laser product report submission. The suggestion reads:
"CDRH recommends (but does not require) labeling on your product that cautions the purchaser with following or similar language: 'CAUTION -LASER LIGHT IS BRIGHT AND BLINDING -DO NOT SHINE AT AIRCRAFT OR VEHICLES AT ANY DISTANCE'."
As of January 2017, it appears that only a few laser pointer manufacturers have added such a statement to their devices.
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FDA public presentation of laser changes
On October 25, 2016, FDA made the first public presentation of its proposed changes to the federal laser performance standard, including the agency's desire to restrict manufacture of green and blue laser pointers.
To understand the nature and status of this proposal, it helps to understand the group to which FDA's proposal was made, and how it fits into FDA's regulatory program.
The TEPRSSC committee
The Technical Electronic Product Radiation Safety Standards Committee is a permanent statutory committee established pursuant to the provisions of the Radiation Control for Health and Safety Act (21 USC 360kk). 30 TEPRSSC consists of 15 voting members. Five are from governmental agencies, five are from "the affected industries" and five are from the general public of which at least one member is from organized labor.
The primary function of TEPRSSC is to provide advice and consultation to the Commissioner of Food and Drugs on the technical feasibility and reasonableness of performance standards for electronic products to control the emissions of electronic product radiation from such products and to review amendments to such standards before being prescribed by FDA.
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FDA is required to consult with TEPRSSC before prescribing standards for radiation emissions from electronic products. At the October 2016 meeting, the committee was asked to review FDA questions and proposals on nine topics, one of which was "laser products." For the laser product topic, the areas of interest were: an update to amendments to the laser rule, light detection and ranging (LIDAR), laser data (Light FidelityLiFi)/energy transfer, illumination applications and infrared applications. 34 The FDA's meeting summary notes "There was significant discussion about the best approach to reduce risks associated with laser pointers. There was also discussion related to the safety concerns and engineering controls for LIPs (Laser Illuminated Projectors). Members of the committee generally agreed with FDA's proposals, while also raising concerns that FDA should note for further consideration." 35 
Background to FDA's 2016 laser proposals
On June 24, 2013, FDA "proposed amending regulations applicable to laser products -those are found in 21 CFR Subchapter J -in order to update its standard."
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The 2013 proposed amendment was based on older IEC and ANSI standards, which had been updated during FDA's development of the proposed amendment. Many comments submitted to the agency wanted FDA to use the newer IEC and ANSI standards.
The 2013 proposal was dropped. As FDA said at the TEPRSSC meeting, "[A]lmost practically out of the starting block, our standard would need some revisions based on these updated standards that came shortly afterwards. So we have been in the process of drafting a re-proposed amendment. Numerous changes have been included…."
Laser pointer-related changes proposed by FDA
FDA's representative 38 told TEPRSSC that the agency was responding to the increased use of laser products by consumers, and the increased exposure of the general public to laser radiation: "We feel that laser emissions are increasingly encountered outdoors and in the home, as opposed to academic or work environments where they typically have been found when the laser rule was first promulgated. So in the future, we think exposures to laser light radiation will be as commonplace as exposure to electromagnetic radiation, let's say, from communication systems like cell phones." 39 The following items list FDA's October 2016 proposed changes that may affect laser pointers.
• Defining the term "laser pointer"
• "Exclude certain wavelengths [of laser pointers] to decrease the public health risk from flash blinding."
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• Modifying the definition of surveying, leveling and alignment (SLA) laser products.
The first two items are discussed below. The third item was not discussed at TEPRSSC, and might not affect laser pointers since they would have their own new definition and would no longer be classified as SLA laser products.
New definition of laser pointer
As discussed earlier, the term "laser pointer" does not appear in the U.S. federal laser regulations, 21 CFR 1040.10 and 1040.11. To update the regulations, FDA told TEPRSSC it is considering adding the following definition:
Handheld laser products designed for batterypowered operation that are manufactured, designed, intended or promoted to provide illumination, designation of a target or point of origin, or sighting, with no associated technological or scientific purpose for the laser's emission.
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FDA clarified: "[I]n other words, just because a product points and it looks like a laser pointer doesn't mean it's necessarily a laser pointer if you're using the emission for a purpose that has a technological use."
The proposed definition then further states:
Laser products are not excluded as laser pointers when used for visual entertainment, vision disruption, to startle, or novelty purposes. 42 This appears to mean that laser products are included in the laser pointer definition if they are used for visual entertainment, vision disruption, to startle or for novelty purposes.
Use of color as a control mechanism
FDA reviewed the eye's sensitivity to green and blue light under dark-adapted (scotopic) vision, presenting the chart in Figure 3 . The three circled areas show how, for a dark-adapted human eye (dashed curve), red light is perceived as much dimmer than equivalent amounts of blue and green light.
FDA noted that "the hazard from flash blinding is significantly reduced when laser pointers emit in the red/orange wavelengths of 615 nm or longer. The hazard from laser aircraft illuminations would be effectively eliminated if green and blue laser pointers were not available. Colors at 615 nm and longer, viewed with night-adapted vision, appear only 1.4% as bright as green at the commonly manufactured 532."
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Green and blue laser pointers are defective
Based on this analysis and considering the thousands of laser illuminations of aircraft each year in the U.S. (95% of which were green or blue in 2016), FDA is proposing that it is defective for a laser pointer to emit green or blue light.
This determination uses a definition of "defective" as applied to electronic products which is in 21 CFR 1003.2:
For the purpose of this part, an electronic product shall be considered to have a defect which relates to the safety of use by reason of the emission of electronic product radiation if: … (b) It is a product which utilizes electronic product radiation to accomplish its primary purpose and from which such emissions are intended, and as a result of its design, production or assembly it; … (2) Without regard to the design specifications of the product, emits electronic product radiation unnecessary to the accomplishment of its primary purpose which creates a risk of injury, including genetic injury to any person….
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Defective products cannot be manufactured (except under a variance)
Under this designation, "manufacturers would be prohibited from manufacturing laser pointers" 45 from 400 nm (deep violet) to 609 nm (red-orange). A manufacturer could apply for a variance from FDA: "Let's say you have a good reason to have a green laser pointer for sighting purposes, the FDA could grant a variance [to manufacture a green pointer] for a specific use." 46 Manufacture of pointers from 610 nm to 710 nm (deep red) would be permitted. As under FDA's current enforcement, the maximum power output would be limited to Class IIIa (3R), e.g. less than 5 milliwatts.
Lasers outside the range of 400 -710 nm are not visible to the human eye under FDA's definition of visible emissions. They do not pose a visual interference hazard to aviation and so would not be regulated as a visual interference hazard under the definition of laser pointer.
FDA does not have authority to ban individual possession of 400-609 nm laser pointers. Persons already owning such pointers, or who build their own for personal, non-commercial use would not be restricted from possession by FDA. (There may be some state or local laws that currently apply 47 and FDA noted that "as a practical matter, we envision that just like any other hazardous product that has been determined to be defective, that state and local … ordinances and laws would be put in place that would likely deal with the use of green and blue laser pointers.") 48 The "risk of injury" listed in 21 CFR 1003.2(b)(2) refers to injury caused by an aircraft accident. The FDA presentation and questions for TEPRSSC were focused on the problem of aircraft illumination hazards. 49 The proposal to limit laser pointers to the 610-710 nm range was not presented as a way to reduce eye injuries.
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"Defective" gives additional authority
The designation of 400-609 nm laser pointers as "defective" gives FDA additional enforcement authority over newly manufactured pointers.
Dr. Donald Miller, Chief Medical Officer for Radiological health at FDA's Center for Devices and Radiological health told the TEPRSSC committee "Defect has a very specific meaning in our regulations, and defect or a failure to comply to EPRC [electronic product radiation control] regulations gives us very specific authorities and powers amongst which are the ability to require the manufacturer to repair, replace, or repurchase a defective device, defective product. Whether that would be practicable, effective, or even possible in the situation of laser pointers, I don't know, but it is an authority that we have under existing regulations for a defective product."
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Restrictions based on color make control easier
A key feature of the FDA's proposal is to make laser pointer control easier for importation and manufacture; and for any state or local restrictions that might be enacted to regulate the sale, possession or use of laser pointers.
If a laser pointer's beam is any color other than red or red-orange, it would be defective. For example, a customs official would know instantly that such pointers could not be imported. Similarly, if colorbased state and local restrictions are enacted, a police officer or other authority could take action such as confiscation based solely on the color of the beam.
Enforcement officers still would need to use power meters to determine whether a legal red (610-710 nm) pointer exceeded the 5 mW power limit.
However, this is not as critical from a visual interference standpoint. First, red laser pointers have a dark-adapted visual efficacy about 1.4% that of a green laser pointer. 52 So even if a red pointer was ten times the 5 mW limit, it still would visually appear less bright than a 5 mW green pointer, according to FDA. Second, the vast majority of laser illumination incidents reported to the Federal Aviation Administration involve non-red lasers. Stopping the manufacture of non-red laser pointers would prevent those pointers from being used in any future incident. In addition, any new state and local regulations on sale, possession or use could help reduce the number of future events.
There are two additional potential benefits of colorbased laser pointer control which were not discussed by FDA or TEPRSSC members, but which are listed here: 1) making it easier to manufacture and use pilot protective eyewear, and 2) increasing public awareness of the laser misuse issue.
Keeping protective eyewear simple & effective
The FDA's proposal will likely slow the adoption of 520 nm green diode laser pointers, which are poised to replace the current 532 nm green DPSS laser pointers.
Essentially all glare protection that pilots currently wear protects them against a 532 nm green laser exposure 54 . It is more costly for eyewear manufacturers to attenuate both 532 and 520 nm green wavelengths simultaneously, without adversely affecting other colors of green such as cockpit indicator lights and airport lighting.
Therefore if FDA's proposal results in fewer exposures from 520 nm green diodes, the current 532 nm eyewear will remain effective against green laser exposures and eyewear manufacturers will not have the difficult task of simultaneously blocking 532 and 520 nm while allowing accurate color recognition of other green lights.
Restrictions may increase public awareness
Restricting certain colors may increase public awareness of bright-light hazards.
To use an analogy, as incandescent light bulbs are phased out in favor of compact fluorescent and LED bulbs, and can no longer be easily found for sale, the public becomes aware of the reason: energy efficiency.
Similarly, when the public can no longer purchase certain colors of laser pointers, they will become educated that this is being done to help protect operators of aircraft, vehicles and watercraft.
Variances for special applications
As noted earlier, FDA said that if a manufacturer wants to make non-compliant laser pointers, they can apply to FDA for a variance. If approved, the manufacturer would then be able to manufacture pointers in the 400-609 nm range and/or pointers over 5 mW for a specific market and/or specified persons; for example, law enforcement.
FDA does not have a mechanism for individual use variances. 55 So if a person felt they had a valid purpose -such as pointing out features outdoors in daytime during an architectural tour -that required a highvisibility or high-powered laser pointer, they would not be able to purchase a newly manufactured pointer. (This assumes no manufacturer had a variance to sell to such a user). The person might be able to find a used laser pointer made prior to enactment of the colorbased regulations, or they might simply have to choose a different method to point out or highlight features.
Reaction to the proposal
A TEPRSSC member supporting FDA's proposal was Dr. William E. Irwin, Radiation Control Program director for Vermont, and a certified health physicist. Irwin told FDA's representative "In your presentation you said it presents a public health hazard, and I would agree. I believe that these lasers should be classified as defective. I don't really care that there's anybody that's using a green laser and getting a better emphasis with their slideshow. That makes no difference to me when the comparison is to an aircraft pilot suffering some sort of momentary or even longer debilitation that may put people at risk of a safe landing." we think that these hazards, when they are misused, justify calling them defective, and I don't think so. I think that's a misappropriation of that term. The documents gave us what 'defective' means. The blue and the green do help very much to accomplish their primary purpose, and so I don't think they are defective at all in having that. The risk of injury is the misuse of them, and that cat is out of the bag." 57 But after some discussion by FDA's representative, which included a statement that Senator Schumer had written to FDA three times "asking us to do something about it", 58 McCollough supported the proposal: "Now, if push came to shove, would I rather have improved protection and safety for people in the air? Absolutely, rather than have my green laser pointer the next time I talk, especially since so many presentations have gone electronic and you can move your mouse around. So if that were the direction it went, I would actually be fine with that, though I think it is a bit of a feel-good step that we're doing something that may not actually reduce, just because there's so many out there." 59 Similarly, TEPRSSC member Patrick Murphy (a coauthor of this paper) of the International Laser Display Association initially was skeptical. He pointed out that if FDA simply reduced the allowed laser pointer powers to 1 mW, as is done in most other countries with laser pointer restrictions, this would reduce glare effects more than the FDA's proposal of allowing 610 nm lasers at 5 mW.
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FDA presenter CAPT Dan Hewett (the other paper coauthor) replied that the advantage was "immediately recognizing that someone has a blue laser in their hand or a green laser in their hand and be able to say that this particular product, due to its color alone, is a hazard versus stopping someone and saying I've got to take your green laser and I've got to measure it to determine if it's a1 mW laser or not. And other countries, I think, are not able to do that level of enforcement so --I mean while it sounds like a good idea, I think we have to fold in the practicality." 61 After further discussion, Murphy called the FDA proposal "very interesting for a number of reasons" but did suggest that FDA "prepare a Plan B if, when that comment comes up, a lot of people don't go for [the proposal] for whatever reason."
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Next steps
FDA will take TEPRSSC's comments and advice into consideration, to decide whether to make any changes to the many proposals (most non-laser related) FDA made to the committee.
For the laser amendments, when FDA is ready they would go through standard rule-making procedures. For the public, this starts with the proposed amendments being published in the Federal Register. There would be a time period for public comments which could vary from 30 to 180 days. 63 The comments give input to the FDA: "the agency must base its reasoning and conclusions on the rulemaking record, consisting of the comments, scientific data, expert opinions, and facts accumulated during the pre-rule [example: TEPRSSC] and proposed rule stages." 64 After these processes, FDA has these options: "If the rulemaking record contains persuasive new data or policy arguments, or poses difficult questions or criticisms, the agency may decide to terminate the rulemaking. Or, the agency may decide to continue the rulemaking but change aspects of the rule to reflect these new issues. If the changes are major, the agency may publish a supplemental proposed rule. If the changes are minor, or a logical outgrowth of the issues and solutions discussed in the proposed rules, the agency may proceed with a final rule." 65 
Summary
Misuse of laser pointers by the general public, by pointing them at aircraft in flight, continues to be a concern. In the U.S. the number of incidents almost doubled in 2015 and 2016, compared to the previous four years. Currently, there is an average of over 20 incidents each night reported to FAA. Although thus far there has not been a serious accident, the risk of a pilot being distracted, startled or flash blinded is clear.
One way to help reduce the number and severity of incidents is to reduce the availability of laser pointers, especially green and blue ones which represent 95% of all FAA-reported incidents.
The FDA has made a first-in-the-world proposal to allow manufacture only of red pointers (610-710 nm). By designating all others (400-609 nm) as "defective", this would give the agency additional regulatory authority which makes it much easier for authorities to determine which laser pointers may be imported, manufactured or (depending on state and local laws) sold, owned or used.
An FDA advisory committee appeared to support this proposal. 66 The next step is for FDA to submit this proposal to the Federal Register for public comments, likely as part of a package of overall laser regulation amendments.
If the laser pointer wavelength proposal eventually becomes an FDA regulation, it will only affect manufacturers and importation. There still may be a public safety need for states and localities to build upon the "defective" designation, with additional restrictions as needed for sale, possession and/or use.
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